Considerations for Pharmacoepidemiological Studies of Drug-Cancer Associations.
about
Considerations for Pharmacoepidemiological Studies of Drug-Cancer Associations.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Considerations for Pharmacoepidemiological Studies of Drug-Cancer Associations.
@en
Considerations for Pharmacoepidemiological Studies of Drug-Cancer Associations.
@nl
type
label
Considerations for Pharmacoepidemiological Studies of Drug-Cancer Associations.
@en
Considerations for Pharmacoepidemiological Studies of Drug-Cancer Associations.
@nl
prefLabel
Considerations for Pharmacoepidemiological Studies of Drug-Cancer Associations.
@en
Considerations for Pharmacoepidemiological Studies of Drug-Cancer Associations.
@nl
P2093
P2860
P356
P1476
Considerations for Pharmacoepidemiological Studies of Drug-Cancer Associations.
@en
P2093
Jesper Hallas
Søren Friis
Til Stürmer
P2860
P304
P356
10.1111/BCPT.12946
P577
2017-12-18T00:00:00Z